Cátia Igreja

Cátia Igreja

Auto-generated profile, based on publicly available information

Cátia Igreja

Department for Integrative Evolutionary Biology, Max Planck Institute for Biology Tübingen, Max Planck Ring 9, 72076 Tübingen, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Molecular Cell
Verified
Journal Article
Closed access
DPDaniel Peter
Daniel Peter
CICátia Igreja
Cátia Igreja
RWRamona Weber
Ramona Weber
LWLara Wohlbold
Lara Wohlbold
CWCatrin Weiler
Catrin Weiler
EIElisa Izaurralde
Elisa Izaurralde

1 November 2016 in Molecular Cell
Verified
Journal Article
Closed access
SGStefan Grüner
Stefan Grüner
DPDaniel Peter
Daniel Peter
RWRamona Weber
Ramona Weber
LWLara Wohlbold
Lara Wohlbold
MCMin-Yi Chung
Min-Yi Chung
EIElisa Izaurralde
Elisa Izaurralde

15 September 2011 in Genes & Development
Verified
Journal Article
Closed access
PDF file
CICatia Igreja
Catia Igreja
EIElisa Izaurralde
Elisa Izaurralde
CUP is an eIF4E-binding protein (4E-BP) that represses the expression of specific maternal mRNAs prior to their posterior localization. Here, we show that CUP employs multiple mechanisms to repress the expression of target mRNAs. In addition to inducing translational repression, CUP maintains mRNA targets in a repressed state by promoting their deadenylation and protects deadenylated mRNAs from further degradation. Translational repression and deadenylation are independent of eIF4E binding and require both the middle and C-terminal regions of CUP, which collectively we termed the effector domain. This domain associates with the deadenylase complex CAF1–CCR4–NOT and decapping activators. Accordingly, in isolation, the effector domain is a potent trigger of mRNA degradation and promotes deadenylation, decapping and decay. However, in the context of the full-length CUP protein, the decapping and decay mediated by the effector domain are inhibited, and target mRNAs are maintained in a deadenylated, repressed form. Remarkably, an N-terminal regulatory domain containing a noncanonical eIF4E-binding motif is required to protect CUP-associated mRNAs from decapping and further degradation, suggesting that this domain counteracts the activity of the effector domain. Our findings indicate that the mode of action of CUP is more complex than previously thought and provide mechanistic insight into the regulation of mRNA expression by 4E-BPs.

19 April 2010 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
GHGabrielle Haas
Gabrielle Haas
JBJoerg E. Braun
Joerg E. Braun
CICátia Igreja
Cátia Igreja
FTFelix Tritschler
Felix Tritschler
TNTadashi Nishihara
Tadashi Nishihara
EIElisa Izaurralde
Elisa Izaurralde
Decapping of eukaryotic messenger RNAs (mRNAs) occurs after they have undergone deadenylation, but how these processes are coordinated is poorly understood. In this study, we report that Drosophila melanogaster HPat (homologue of Pat1), a conserved decapping activator, interacts with additional decapping factors (e.g., Me31B, the LSm1–7 complex, and the decapping enzyme DCP2) and with components of the CCR4–NOT deadenylase complex. Accordingly, HPat triggers deadenylation and decapping when artificially tethered to an mRNA reporter. These activities reside, unexpectedly, in a proline-rich region. However, this region alone cannot restore decapping in cells depleted of endogenous HPat but also requires the middle (Mid) and the very C-terminal domains of HPat. We further show that the Mid and C-terminal domains mediate HPat recruitment to target mRNAs. Our results reveal an unprecedented role for the proline-rich region and the C-terminal domain of metazoan HPat in mRNA decapping and suggest that HPat is a component of the cellular mechanism that couples decapping to deadenylation in vivo.

1 June 2017 in Genes & Development
Verified
Journal Article
Open access
PDF file
DPDaniel Peter
Daniel Peter
RWRamona Weber
Ramona Weber
FSFelix Sandmeir
Felix Sandmeir
LWLara Wohlbold
Lara Wohlbold
SHSigrun Helms
Sigrun Helms
EIElisa Izaurralde
Elisa Izaurralde
The eIF4E homologous protein (4EHP) is thought to repress translation by competing with eIF4E for binding to the 5′ cap structure of specific mRNAs to which it is recruited through interactions with various proteins, including the GRB10-interacting GYF (glycine–tyrosine–phenylalanine domain) proteins 1 and 2 (GIGYF1/2). Despite its similarity to eIF4E, 4EHP does not interact with eIF4G and therefore fails to initiate translation. In contrast to eIF4G, GIGYF1/2 bind selectively to 4EHP but not eIF4E. Here, we present crystal structures of the 4EHP-binding regions of GIGYF1 and GIGYF2 in complex with 4EHP, which reveal the molecular basis for the selectivity of the GIGYF1/2 proteins for 4EHP. Complementation assays in a GIGYF1/2-null cell line using structure-based mutants indicate that 4EHP requires interactions with GIGYF1/2 to down-regulate target mRNA expression. Our studies provide structural insights into the assembly of 4EHP–GIGYF1/2 repressor complexes and reveal that rather than merely facilitating 4EHP recruitment to transcripts, GIGYF1/2 proteins are required for repressive activity.

2 September 2014 in Nature Communications
Verified
Journal Article
Open access
CICátia Igreja
Cátia Igreja
DPDaniel Peter
Daniel Peter
CWCatrin Weiler
Catrin Weiler
EIElisa Izaurralde
Elisa Izaurralde
EIF4E-binding proteins (4E-BPs) are a widespread class of translational regulators that share a canonical (C) eIF4E-binding motif (4E-BM) with eIF4G. Consequently, 4E-BPs compete with eIF4G for binding to the dorsal surface on eIF4E to inhibit translation initiation. Some 4E-BPs contain non-canonical 4E-BMs (NC 4E-BMs), but the contribution of these motifs to the repressive mechanism—and whether these motifs are present in all 4E-BPs—remains unknown. Here, we show that the three annotated Drosophila melanogaster 4E-BPs contain NC 4E-BMs. These motifs bind to a lateral surface on eIF4E that is not used by eIF4G. This distinct molecular recognition mode is exploited by 4E-BPs to dock onto eIF4E–eIF4G complexes and effectively displace eIF4G from the dorsal surface of eIF4E. Our data reveal a hitherto unrecognized role for the NC4E-BMs and the lateral surface of eIF4E in 4E-BP-mediated translational repression, and suggest that bipartite 4E-BP mimics might represent efficient therapeutic tools to dampen translation during oncogenic transformation.